Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
W V Med J ; 111(5): 30-4, 2015.
Article in English | MEDLINE | ID: mdl-26521533

ABSTRACT

Breast cancer is the most frequently diagnosed malignancy in women in the United States. It is the second most common malignancy to cause death, with approximately 39,000 women dying of breast cancer in the United States in 2013. Triple negative breast cancer is defined as the absence of estrogen, progesterone and human epidermal growth factor receptor 2 receptors. It has been associated with a higher incidence in African American women, a younger age and a more advanced stage at diagnosis, and an inferior overall survival. To recognize the differences of our West Virginia community population when compared to the national average, we conducted a retrospective review of all patients diagnosed with breast cancer from 2000-2012.


Subject(s)
Triple Negative Breast Neoplasms , Black or African American , Female , Hospitals, University , Humans , Middle Aged , Neoplasm Staging , Outcome Assessment, Health Care , Retrospective Studies , Survival Rate , Triple Negative Breast Neoplasms/mortality , Triple Negative Breast Neoplasms/pathology , Triple Negative Breast Neoplasms/therapy , West Virginia , White People
2.
3.
J Med Food ; 16(12): 1079-85, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24328700

ABSTRACT

Clostridium difficile is the leading cause of hospital-acquired antibiotic-associated diarrhea worldwide; in addition, the proliferation of antibiotic-resistant C. difficile is becoming a significant problem. Virgin coconut oil (VCO) has been shown previously to have the antimicrobial activity. This study evaluates the lipid components of VCO for the control of C. difficile. VCO and its most active individual fatty acids were tested to evaluate their antimicrobial effect on C. difficile in vitro. The data indicate that exposure to lauric acid (C12) was the most inhibitory to growth (P<.001), as determined by a reduction in colony-forming units per milliliter. Capric acid (C10) and caprylic acid (C8) were inhibitory to growth, but to a lesser degree. VCO did not inhibit the growth of C. difficile; however, growth was inhibited when bacterial cells were exposed to 0.15-1.2% lipolyzed coconut oil. Transmission electron microscopy (TEM) showed the disruption of both the cell membrane and the cytoplasm of cells exposed to 2 mg/mL of lauric acid. Changes in bacterial cell membrane integrity were additionally confirmed for VCO and select fatty acids using Live/Dead staining. This study demonstrates the growth inhibition of C. difficile mediated by medium-chain fatty acids derived from VCO.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridioides difficile/drug effects , Fatty Acids/pharmacology , Plant Oils/pharmacology , Caprylates/pharmacology , Coconut Oil , Colony Count, Microbial , Decanoic Acids/pharmacology , Drug Resistance, Bacterial , Fatty Acids/analysis , Lauric Acids/pharmacology , Metronidazole/pharmacology , Microbial Viability/drug effects , Microscopy, Electron, Transmission , Plant Oils/analysis
4.
Rare Tumors ; 5(3): e52, 2013.
Article in English | MEDLINE | ID: mdl-24179664

ABSTRACT

Extrapulmonary small cell carcinomas (EPSCC) are extremely rare. Most reports indicate success with therapy directed at the tumor as if it was pulmonary small cell carcinoma Primary small cell carcinoma of the breast is an uncommon form of EPSCC. Differentiating between a primary small cell carcinoma of the breast from metastatic disease to the breast is very important. According to the literature, there have been approximately 70 cases reported worldwide. Of these cases, only two cases are documented in men. Prognosis is varied and depends on stage of disease at presentation. A combination of surgery, chemotherapy and/or radiation is required to adequately treat patients with small cell carcinoma of the breast. We present a case of a male patient diagnosed with stage IV non-small cell lung carcinoma first and then subsequently diagnosed with a concurrent small cell carcinoma of the breast responding to treatment with concurrent chemotherapy and radiation.

SELECTION OF CITATIONS
SEARCH DETAIL
...